Amcor, Berry Global Progress Toward Completion of Merger-March 2024-www.financetom.com

Amcor, Berry Global Progress Toward Completion of Merger

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Amcor, Berry Global Progress Toward Completion of Merger

Mar 11, 2025 5:09 AM

07:52 AM EDT, 03/11/2025 (MT Newswires) -- Amcor ( AMCCF ) and Berry Global Group ( BERY ) said

Tuesday the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act expired, meeting a key condition for their merger.

The companies said it received additional regulatory approvals, including antitrust clearances from China and Brazil.

The companies continue to expect the transactions to close in the middle of the calendar year 2025.

Previous page： Logility Supply Chain Solutions Says Bidder Pulled Unsolicited Cash Takeover Proposal of $15 a Share Next page： Why Is Protagonist Therapeutics Stock Trading Higher On Monday?

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Logility Supply Chain Solutions Says Bidder Pulled Unsolicited Cash Takeover Proposal of $15 a Share

Mar 10, 2025

10:02 AM EDT, 03/10/2025 (MT Newswires) -- Logility Supply Chain Solutions ( LGTY ) said Monday that the unsolicited, non-binding proposal to acquire all of its outstanding common shares for $15 per share in cash has been withdrawn by the bidder. The company confirmed receiving the proposal on Friday and did not disclose any reason for the withdrawal. Logility said...

Why Is Protagonist Therapeutics Stock Trading Higher On Monday?

Mar 10, 2025

On Monday, Protagonist Therapeutics, Inc ( PTGX ). announced topline results from ANTHEM-UC Phase 2b study of icotrokinra (JNJ-2113) in adults with moderately to severely active ulcerative colitis (UC). The study conducted by Protagonist’s collaboration partner, Johnson & Johnson ( JNJ ), met its primary endpoint of clinical response in all icotrokinra dose groups evaluated. Additionally, the study demonstrated clinically meaningful...

New York sues Allstate over data breach, security lapses

Mar 10, 2025

NEW YORK, March 10 (Reuters) - New York state sued Allstate ( ALL ) on Monday, accusing the insurer's National General unit of failing to report a data breach that exposed drivers' license numbers, and failing to develop reasonable safeguards to protect policyholders' private information. The lawsuit by New York Attorney General Letitia James was filed in a state court...

US energy secretary says global warming a side effect of modern economy

Mar 10, 2025

HOUSTON (Reuters) -U.S. Energy Secretary Chris Wright said on Monday that global warming is a side effect of building the modern world, and vowed to end former President Joe Biden's climate policies to promote growth of fossil fuels. Wright made the comments to kick off CERAWeek, the nation's largest energy conference, in Houston. The Trump administration will treat climate change...